SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042439
Filing Date
2023-08-14
Accepted
2023-08-14 16:20:15
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20230630.htm   iXBRL 10-Q 2874329
2 EX-31.1 sprb-ex31_1.htm EX-31.1 21335
3 EX-31.2 sprb-ex31_2.htm EX-31.2 19691
4 EX-32.1 sprb-ex32_1.htm EX-32.1 10485
5 EX-32.2 sprb-ex32_2.htm EX-32.2 10668
  Complete submission text file 0000950170-23-042439.txt   8019292

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sprb-20230630_def.xml EX-101.DEF 146201
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230630.xsd EX-101.SCH 48281
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sprb-20230630_cal.xml EX-101.CAL 40364
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230630_pre.xml EX-101.PRE 265486
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230630_lab.xml EX-101.LAB 390265
50 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230630_htm.xml XML 1236768
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 231170592
SIC: 2834 Pharmaceutical Preparations